ARTIMPLANT YEAR-END REPORT 2010 Västra Frölunda, Sweden, February 10, 2011 · Net revenue for the fourth quarter amounted to SEK 3.5 million (5.8) and for January-December SEK 18.5 million (24.0).* · The net loss for the fourth quarter totaled SEK 7.4 million (5.4) and for January-December SEK 22.4 million (18.6). · Earnings per stock unit for the fourth quarter amounted to SEK -0.07 (-0.09) and for January-December SEK -0.32 (-0.31). · Artimplant's own sales as a proportion of total sales continued to increase and were equivalent to 70% (60) of product sales for the fourth quarter, equivalent to 61% (37) for the full year. · Compared to 2009, Artimplant's own sales in the USA more than doubled whilst revenue from license sales was halved. · Artimplant's rights issue was subscribed up to 189% and generated capital input for the Company of approximately SEK 38.5 million before issue costs. · Artimplant's strategy has been focused on marketing with increased intensity in own sales in the USA. · Artimplant implemented staff cutbacks in Sweden during the fall of 2010 equivalent to an annual saving of approximately SEK 5 million once the periods of notice came to an end. At the same time the Company has employed more product specialists in the USA. · The Board proposes that no dividend be paid for 2010. Events after the period-end · The launch of the new Artelon® Tissue Reinforcement products has commenced. N. B. This is a translation from Swedish. The Swedish version shall always take precedence. Artimplant will hold a telephone conference by reason of this report on February 10, 2011 at 11 am (CET). For further information see www.artimplant.com. * Figures in brackets refer to the corresponding period last year. For further information, please contact: Hans Rosén, CEO, phone 46 (0)31-746 56 00, 46 (0)708 58 34 70, hans.rosen@artimplant.com (hans.rosen@artimplant.com) Lars-Johan Cederbrant, CFO, phone 46 (0)31-746 56 54, 46 (0)703 01 68 54, lars-johan.cederbrant@artimplant.com (lars-johan.cederbrant@artimplant.c om) Further information is available at www.artimplant.com (http://www.artimplant.com). To subscribe to future press releases please go to www.artimplant.com/investors-media/subscribe-to-press-releases.html (htt p://www.artimplant.com/investors-media/subscribe-to-press-releases.html)
ARTIMPLANT YEAR-END REPORT 2010
| Source: Artimplant AB